RxDoctor Payments DataLook up a doctor →

Steven Yakubov, MD

Interventional Cardiology · Columbus, OHNPI 1316942782

Payments from drug & device makers

$3,228,544in general payments, 2019–2025

Across 1,933 payments — averaging $1670.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$1.4M
  • Medtronic$1.3M
  • Johnson & Johnson$141K
  • Edwards Lifesciences$109K
  • Atricure, Inc.$61K
  • Anika Therapeutics, Inc.$51K
  • plus $132K from 29 others
$83,266in research payments, 2019–2025

Across 61 payments — averaging $1365.01 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$78K
  • Atricure, Inc.$5K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,228,544 in reported general payments places this provider in the 95th percentile of 256 interventional cardiology providers in Ohio.

See all interventional cardiology providers in Ohio

Medicare billing

Part B allowed, 2024
$178,621
Medicare patients
876
Services billed
1,594

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in Columbus

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →